Culturally Adapted Contingency Management for Stimulant Use Disorder
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to develop a culturally adapted contingency management (CM) protocol for Black adults with stimulant use disorder.
Who Is on the Research Team?
Oluwole Jegede, MD, PhD
Principal Investigator
Yale University
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Lead-in Phase
Participants undergo a 4-week lead-in phase before the main treatment begins
Treatment
Participants receive culturally adapted or basic CM over a 12-week period
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Culturally Adapted Contingency Management
How Is the Trial Designed?
3
Treatment groups
Experimental Treatment
Active Control
Participants in this arm will receive the culturally adapted CM over a 12- week treatment period
Participants in this arm will receive the basic CM over a 12- week treatment period
Intensive Outpatient clinic (IOP) at substance use treatment and addiction (SATU) clinic twice every week, one day for group and the other for individual counseling
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.